Oro-buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson's disease: Preliminary analysis from the French COPARK cohort

European Journal of Neurology

Volumn 19, Issue 1, 2012, Pages 28-37

  Perez Lloret, S ^a,b,c   Negre Pages L ^a,b,d   Ojero Senard, A ^a,b   Damier, P ^e   Destee A ^f   Tison, F ^g   Merello, M ^c   Rascol, O ^a,b  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b CNRS   (France)

^c Instituto de Investigaciones Neurologicas Raul Carrera   (Argentina)

^d LN Pharma   (France)

^e NANTES UNIVERSITY HOSPITAL   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Dysarthria; Dysphagia; Non motor symptoms; Parkinson's disease; Sialorrhea

Indexed keywords

AMANTADINE; ANTIDEPRESSANT AGENT; APOMORPHINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR; OPIATE;

AGED; ANTICHOLINERGIC EFFECT; ARTICLE; CLINICAL FEATURE; DEPRESSION; DISEASE SEVERITY; DYSARTHRIA; DYSPHAGIA; FEMALE; HALLUCINATION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HYPERSALIVATION; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; APHASIA; COHORT STUDIES; DYSARTHRIA; FEMALE; FRANCE; HUMANS; MALE; PARKINSON DISEASE; PREVALENCE; SIALORRHEA;

EID: 84055190690     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03402.x     Document Type: Article

References (41)

1. Cersosimo MG, Benarroch EE. Neural control of the gastrointestinal tract: implications for Parkinson disease. Mov Disord 2008; 23: 1065-1075.
2. Chaudhuri KR, Martinez-Martin P. Quantitation of non-motor symptoms in Parkinson's disease. Eur J Neurol 2008; 15(Suppl 2): 2-7.
3. Martinez-Martin P, Schapira AH, Stocchi F, et al. Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 2007; 22: 1623-1629.
4. Muller J, Wenning GK, Verny M, et al. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol 2001; 58: 259-264.
5. Nobrega AC, Rodrigues B, Melo A. Is silent aspiration a risk factor for respiratory infection in Parkinson's disease patients? Parkinsonism Relat Disord 2008; 14: 646-648.
6. Baijens LW, Speyer R. Effects of therapy for dysphagia in Parkinson's disease: systematic review. Dysphagia 2008; 24: 91-102.
7. Feng X, Henriquez VM, Walters JR, Ludlow CL. Effects of dopamine D1 and D2 receptor antagonists on laryngeal neurophysiology in the rat. J Neurophysiol 2009; 102: 1193-1205.
8. Lim A, Leow L, Huckabee ML, Frampton C, Anderson T. A pilot study of respiration and swallowing integration in Parkinson's disease: "on" and "off" levodopa. Dysphagia 2008; 23: 76-81.
9. Nobrega AC, Rodrigues B, Melo A. Silent aspiration in Parkinson's disease patients with diurnal sialorrhea. Clin Neurol Neurosurg 2008; 110: 117-119.
10. Gross RD, Atwood CW Jr, Ross SB, et al. The coordination of breathing and swallowing in Parkinson's disease. Dysphagia 2008; 23: 136-145.
11. Nobrega AC, Rodrigues B, Torres AC, et al. Is drooling secondary to a swallowing disorder in patients with Parkinson's disease? Parkinsonism Relat Disord 2008; 14: 243-245.
12. Proulx M, de Courval FP, Wiseman MA, Panisset M. Salivary production in Parkinson's disease. Mov Disord 2005; 20: 204-207.
13. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
14. Negre-Pages L, Regragui W, Bouhassira D, Grandjean H, Rascol O. Chronic pain in Parkinson's disease: the cross-sectional French DoPaMiP survey. Mov Disord 2008; 23: 1361-1369.
15. Negre-Pages L, Grandjean H, Lapeyre-Mestre M, et al. Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study. Mov Disord 2010; 25: 157-166.
16. Fahn S, Elton RL, and members of the UPDRS committee. Unified Parkinson's disease rating scale. In: Fahn S, Mardsen CD, Goldstein M, eds. Recent Developments in Parkinson's Disease. New York: McMillan, 1987: 153-163.
17. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002; 52: 69-77.
18. Marinus J, Leentjens AF, Visser M, Stiggelbout AM, van Hilten JJ. Evaluation of the hospital anxiety and depression scale in patients with Parkinson's disease. Clin Neuropharmacol 2002; 25: 318-324.
19. Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 1995; 4: 241-248.
20. Peto V, Jenkinson C, Fitzpatrick R. PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol 1998; 245(Suppl 1): S10-S14.
21. Razmy A, Lang AE, Shapiro CM. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Arch Neurol 2004; 61: 97-102.
22. Miller N, Allcock L, Hildreth AJ, et al. Swallowing problems in Parkinson disease: frequency and clinical correlates. J Neurol Neurosurg Psychiatry 2009; 80: 1047-1049.
23. Potulska A, Friedman A, Krolicki L, Spychala A. Swallowing disorders in Parkinson's disease. Parkinsonism Relat Disord 2003; 9: 349-353.
24. Narula J, Zoghbi WA, Chandrashekhar Y. On fishing expeditions, laws of fishing, and good fishermen. JACC Cardiovasc Imaging 2010; 3: 1086-1088.
25. Chou KL, Evatt M, Hinson V, Kompoliti K. Sialorrhea in Parkinson's disease: a review. Mov Disord 2007; 22: 2306-2313.
26. Jost WH. Gastrointestinal motility problems in patients with Parkinson's disease. Effects of antiparkinsonian treatment and guidelines for management. Drugs Aging 1997; 10: 249-258.
27. Sapir S, Ramig L, Fox C. Speech and swallowing disorders in Parkinson disease. Curr Opin Otolaryngol Head Neck Surg 2008; 16: 205-210.
28. Miller N, Allcock L, Jones D, et al. Prevalence and pattern of perceived intelligibility changes in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007; 78: 1188-1190.
29. Perez-Lloret S, Piran-Arce G, Rossi M, et al. Validation of a new scale for the evaluation of sialorrhea in patients with Parkinson's disease. Mov Disord 2007; 22: 107-111.
30. Alfonsi E, Versino M, Merlo IM, et al. Electrophysiologic patterns of oral-pharyngeal swallowing in parkinsonian syndromes. Neurology 2007; 68: 583-589.
31. Kalf JG, Smit AM, Bloem BR, Zwarts MJ, Munneke M. Impact of drooling in Parkinson's disease. J Neurol 2007; 254: 1227-1232.
32. Leibner J, Ramjit A, Sedig L, et al. The impact of and the factors associated with drooling in Parkinson's disease. Parkinsonism Relat Disord 2010; 16: 67-70.
33. Manor Y, Balas M, Giladi N, Mootanah R, Cohen JT. Anxiety, depression and swallowing disorders in patients with Parkinson's disease. Parkinsonism Relat Disord 2009; 15: 453-456.
34. Barichella M, Cereda E, Pezzoli G. Major nutritional issues in the management of Parkinson's disease. Mov Disord 2009; 24: 1881-1892.
35. Wilson K, Mottram P. A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis. Int J Geriatr Psychiatry 2004; 19: 754-762.
36. Mavissakalian MR. Imipramine vs. sertraline in panic disorder: 24-week treatment completers. Ann Clin Psychiatry 2003; 15: 171-180.
37. Uher R, Farmer A, Henigsberg N, et al. Adverse reactions to antidepressants. Br J Psychiatry 2009; 195: 202-210.
38. De LM, Santens P, De BM, Boon P, Van BJ. Levodopa-induced alterations in speech rate in advanced Parkinson's disease. Acta Neurol Belg 2006; 106: 19-22.
39. De LM, Santens P, De BM, et al. The effect of levodopa on respiration and word intelligibility in people with advanced Parkinson's disease. Clin Neurol Neurosurg 2007; 109: 495-500.
40. Ho AK, Bradshaw JL, Iansek R. For better or worse: The effect of levodopa on speech in Parkinson's disease. Mov Disord 2008; 23: 574-580.
41. Plowman-Prine EK, Sapienza CM, Okun MS, et al. The relationship between quality of life and swallowing in Parkinson's disease. Mov Disord 2009; 24: 1352-1358.